The interim analysis shows Moderna’s vaccine could be up to 94.5% effective. The company plans to ask the FDA for authorization “in the coming weeks” after safety data is available.


By Arlene Huff

Arlene Huff is the founding member of Golden State Online. Before that She was a general assignment reporter. A native Californian, she graduated from the University of California with a degree in medical anthropology and global health. She currently lives in Los Angeles.

Leave a Reply

Your email address will not be published. Required fields are marked *